A detailed history of Wolverine Trading, LLC transactions in Krystal Biotech, Inc. stock. As of the latest transaction made, Wolverine Trading, LLC holds 1,538 shares of KRYS stock, worth $253,508. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,538
Holding current value
$253,508
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$174.7 - $213.66 $268,688 - $328,609
1,538 New
1,538 $279,000
Q3 2023

Nov 15, 2023

SELL
$108.51 - $130.22 $36,133 - $43,363
-333 Reduced 13.94%
2,055 $238,000
Q2 2023

Aug 23, 2023

BUY
$78.48 - $130.32 $187,410 - $311,204
2,388 New
2,388 $280,000

Others Institutions Holding KRYS

About Krystal Biotech, Inc.


  • Ticker KRYS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,664,300
  • Market Cap $4.23B
  • Description
  • Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...
More about KRYS
Track This Portfolio

Track Wolverine Trading, LLC Portfolio

Follow Wolverine Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.